OssDsign AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0012570448
SEK
10.70
-0.12 (-1.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About OssDsign AB stock-summary
stock-summary
OssDsign AB
Pharmaceuticals & Biotechnology
OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
Company Coordinates stock-summary
Company Details
Uppsala Business Park, Rapsgatan 7 , UPPSALA None : 754 50
stock-summary
Tel: 46 18 553993
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Simon Cartmell
Independent Chairman of the Board
Dr. Viktor Drvota
Director
Dr. Hakan Engqvist
Director
Mr. Newton Aguiar
Independent Director
Mr. Anders Qvarnstrom
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
47 Million
(Quarterly Results - Jun 2025)
Net Profit:
-8 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 1,204 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.60

stock-summary
Return on Equity

-10.01%

stock-summary
Price to Book

3.47